跳到正文
原文
NEJM· @NEJM · X·· 2026-10-19AI 评分37
AI 导读

每日抗逆转录病毒治疗的完全依从性可能具有挑战性。一项在非洲开展的3b期试验比较了每日ART与更长间隔给药的ART方案。IMPALA试验的研究结果在一段新的Quick Take视频中进行了总结。https://nej.md/3TGzG2Z

正文

Full adherence to daily antiretroviral therapy can be challenging. A phase 3b trial in Africa compared daily ART with a longer-acting ART regimen. Research findings from the IMPALA trial are summarized in a new Quick Take video. https://nej.md/3TGzG2Z

来源:NEJM · x.com